Role of P2X7 receptors in the development of diabetic retinopathy

doi:10.4239/wjd.v5.i2.141

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6458)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

438

WORD

306

HTML

3443

Figures (1-3)

264

Sum=4451

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1032

Download

963

Sum=1995

Apr 15, 2014 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Diabetes. Apr 15, 2014; 5(2): 141-145
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.141

Full Size Figure Download Figure

Figure 2 Typical changes of electroretinography after intravitreal injection (IV) of benzoylbenzoyl adenosine triphosphate (50 nmol) or physiological saline solution in an alloxan-induced diabetic rabbit. The amplitudes of a and b waves and oscillatory potentials were reduced in the BzATP-treated eye. From Sugiyama et al[32] with permission from Archives of Ophthalmology. BzATP: Benzoylbenzoyl adenosine triphosphate.

Citation: Sugiyama T. Role of P2X₇ receptors in the development of diabetic retinopathy. World J Diabetes 2014; 5(2): 141-145
URL: https://www.wjgnet.com/1948-9358/full/v5/i2/141.htm
DOI: https://dx.doi.org/10.4239/wjd.v5.i2.141